Purna Thakker, founder and CEO of ADPT Solution, discusses common issues that companies face with FDA regulations at CPHI ...

Tara Dougal, content director, Pharma, Informa Markets, discusses successes and insights from this year’s CPHI North America ...

The company’s presentation at ASGCT includes preliminary data results for a child who received the gene therapy. Regeneron presented results from an ongoing Phase I/II clinical trial for its ...

A greater understanding of molecular and cellular biology and technological advancements are revolutionizing the field of ...

The company is presenting preclinical data at the American Society of Gene & Cell Therapy annual meeting that supports the potential of the company’s CAP-002 gene therapy for correcting neurological ...

Experiments conducted by the downstream technology team at Spark Therapeutics involving metal ion-containing additives showed improved capsid clearance in AAV production.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, ...

The report covers the major achievements of the office during 2023, including notable drug approvals, publications, guidances, workshops, webinars, and meetings.

Explore how Rentschler Biopharma duels biopharmaceutical innovation, spanning from pioneering biological products to ...

Meeta B. Kratz (Global Vice President, Product Management & Marketing, Lonza Capsule and Health Ingredients) talks about ...

The request for more information was received weeks after an application to the FTC was refiled to approve the deal. The United States Federal Trade Commission (FTC) is seeking more information on ...

Bill Humphries (CEO, Alcami) dives into an overview of Alcami's capabilities and how they value their client's innovations.